 However, the
Writing Committee considered there is likely to be
important variability in patient values due to the lack of
clear beneÔ¨Åt of one approach over the other.
Factors such as the severity of ischaemia and tissue loss
(e.g., WIfI staging) and patient suitability for the procedure and presence of comorbidities, as well as the availability of expertise and costs of the procedures (which
may vary between locations and countries) drives decision making in relation to the type